Screening and management of major endocrinopathies during pregnancy: an update

4Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Endocrinopathies during pregnancy constitute a challenging issue, being prevalent and requiring appropriate management to avoid maternal and fetal complications. This review aims to summarize and present major endocrine problems during pregnancy, the appropriate screening, maternal monitoring and management, fetal monitoring, and follow-up. Glucose metabolism, thyroid function, as well as calcium and vitamin D metabolism are the main endocrine domains that should be screened and monitored during pregnancy. Gestational diabetes mellitus (GDM) is the most prevalent endocrine disease during pregnancy, followed by thyroid disorders. Specific recommendations are provided for the optimal clinical care of pregnant women and their offspring for GDM, thyroid disorders, and calcium and vitamin D disorders.

Cite

CITATION STYLE

APA

Paschou, S. A., Bletsa, E., Papazisi, M., Mili, N., Kanouta, F., Kassi, G. N., … Lambrinoudaki, I. (2023, April 1). Screening and management of major endocrinopathies during pregnancy: an update. Endocrine. Springer. https://doi.org/10.1007/s12020-022-03237-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free